Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway

L Yang, T Zhang, P Wang, W Chen, W Liu, X He… - Cell Biology and …, 2023 - Springer
V-domain immunoglobulin suppressor of T-cell activation (VISTA), an important negative
checkpoint protein, participates in immunoregulation. Systemic lupus erythematosus (SLE) …
被引用次数：1 相关文章

Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway.

L Yang, T Zhang, P Wang, W Chen, W Liu… - Cell Biology and …, 2023 - europepmc.org
V-domain immunoglobulin suppressor of T-cell activation (VISTA), an important negative
checkpoint protein, participates in immunoregulation. Systemic lupus erythematosus (SLE) …

Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway

L Yang, T Zhang, P Wang, W Chen… - Cell biology and …, 2023 - pubmed.ncbi.nlm.nih.gov
V-domain immunoglobulin suppressor of T-cell activation (VISTA), an important negative
checkpoint protein, participates in immunoregulation. Systemic lupus erythematosus (SLE) …